Harmony Biosciences (HRMY) reported Q4 EPS of $1.01, $0.44 better than the analyst estimate of $0.57. Revenue for the quarter came in at $128.31 million versus the consensus estimate of $127.65 million.
Harmony Biosciences (HRMY) reported Q4 EPS of $1.01, $0.44 better than the analyst estimate of $0.57. Revenue for the quarter came in at $128.31 million versus the consensus estimate of $127.65 million.